India Urology Drugs Market, By Drug Class (Anticholinergic/ Antispasmodic Agents, Skeletal Muscle Relaxants, Alpha Blockers, Others), By Type (Original Drugs v/s Generic Drugs), By Application (Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Urinary Incontinence, Kidney/Bladder Stone, Erectile Dysfunction, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Region, Competition Forecast & Opportunities, FY2027
Market Report I 2022-12-01 I 74 Pages I TechSci Research
India urology drugs market is anticipated to grow with an estimated CAGR in the forecast years FY2023-FY2027, on the grounds of increasing instances of urology diseases and urinary tract disorders. Increasing advancement in the pharmaceutical industry regarding urinary disease treatment is further driving the growth of the India urology drugs market in the upcoming five years.
Urology drugs are the pharmaceuticals that are used a treatment for urogenital conditions and diseases like urinary inconsistences, prostatic hyperplasia, and erectile dysfunctions. Urology is a part of healthcare sector that deals with the diseases of male and female urinary tract including reproductive organs. Urinary tract includes organs like kidney, ureters, bladder, and urethra. Reproductive organs like penis, testes, scrotum, prostate, etc. involved in the conditions is also treated with use of urology drugs. Advancing pharmaceutical industry is consistently developing various therapeutic drugs like Detrol (tolterodine), Enablex (darifenacin), Oxytrol or Ditropan XL (oxybutynin), Regurin and Sanctura (trospium chloride), Toviaz (fesoterodine), Vesicare (solifenacin), Sanctura (trospium).
Increasing Instances of Urinary Diseases Drive Market Growth
Rapidly increasing instances of urinary diseases and disorders in the country is anticipated to further drive the growth of the India urology drugs market in the upcoming five years. Approximately, 800 per million population in India have risk of chronic kidney diseases as per the report from 2020. The increasing risk of prostate cancer also supports the growth of the India urology drugs market in the next five years. Prostate cancer is the second leading site of cancer instances in the Indian males in metro cities like Delhi, Kolkata, Pune and Thiruvananthapuram.
Advancing Pharma Industry Supports Market Growth
Rapidly increasing advancement and product development is driving the growth of the India urology drugs market in the upcoming five years. Moreover, increasing investment in the research sector of the drug development is further anticipated to support the growth of the India urology drugs market in the next five years. Recent drug developments like antimuscarinic and beta-3-agonist drugs advances the growth of the India urology drugs market in the future five years.
Also, therapeutic drugs like Detrol (tolterodine), Enablex (darifenacin), Oxytrol or Ditropan XL (oxybutynin), among other urology drugs are some of the advanced pharmaceutical products that are further substantiating the growth of the India urology drugs market in the forecast years.
Market Segmentation
The India urology drugs market segmentation is based on drug class, type, application, distribution channel, competitional landscape, and regional distribution. Based on drug class, the market is further fragmented into anticholinergic/ antispasmodic agents, skeletal muscle relaxants, alpha blockers, and others. Also based on type, the market is further divided between original drugs and generic drugs. Based on application, the market is segmented into benign prostatic hyperplasia (BPH), prostate cancer, urinary incontinence, kidney/bladder stone, erectile dysfunction, and others. The market segmentation based on distribution channel is bifurcated into hospital pharmacies, retail pharmacies, and online. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among North India region, South India region, East India region, and West India region.
Company Profile
Astellas Pharma India Pvt Ltd, Endo Pharmaceuticals, Sanofi India, Pfizer Ltd., Innovexia Lifesciences, Salvus Pharma, Silhos Pharma Ltd., are some of the major market players in the country that lead the market growth analysis. New market players are also actively entering the market in the recent years and further strengthening the growth of the future market growth.
Report Scope:
In this report, India Urology drugs market is segmented into following categories, in addition to the industry trends which have also been detailed below:
- India Urology Drugs Market, By Drug Class:
o Anticholinergic/ Antispasmodic Agents
o Skeletal Muscle Relaxants
o Alpha Blockers
o Others
- India Urology Drugs Market, By Type:
o Original Drugs
o Generic Drugs
- India Urology Drugs Market, By Application:
o Benign Prostatic Hyperplasia (BPH)
o Prostate Cancer
o Urinary Incontinence
o Kidney/Bladder Stone
o Erectile Dysfunction
o Others
- India Urology Drugs Market, By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online
- India Urology Drugs Market, By Region:
o South
o West
o North
o East
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in India urology drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on India Urology Drugs Market
4. Executive Summary
5. Voice of Customers
6. India Urology Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume (Thousand Units)
6.2. Market Share & Forecast
6.2.1. By Drug Class (Anticholinergic/Antispasmodic Agents, Skeletal Muscle Relaxants, Alpha Blockers, Others)
6.2.2. By Type (Original Drugs v/s Generic Drugs)
6.2.3. By Application (Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Urinary Incontinence, Kidney/Bladder Stone, Erectile Dysfunction, Others)
6.2.4. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online)
6.2.5. By Company (FY2021)
6.2.6. By Region
6.2.6.1. By State (Top 3 States)
6.3. Product Market Map
7. India Anticholinergic/Antispasmodic Urological Agents Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume (Thousand Units)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Distribution Channel
8. India Skeletal Muscle Relaxants Urology Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume (Thousand Units)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Distribution Channel
9. India Alpha Blockers Urology Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume (Thousand Units)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. Pricing Analysis
14. Import-Export Analysis
15. India Economic Profile
16. Competitive Landscape
16.1. Competition Outlook
16.2. Company Profiles
16.2.1. Detailed Analysis of Marketing Activities of Top 3 Players Profiles
16.2.1.1. Astellas Pharma India Pvt Ltd
16.2.1.2. Endo Pharmaceuticals
16.2.1.3. Sanofi India
16.2.1.4. Pfizer Ltd.
16.2.1.5. Innovexia Lifesciences
16.2.1.6. Salvus Pharma
16.2.1.7. Silhos Pharma Ltd.
17. Go-To-Market Strategies (Covers detailed analysis of strategies to be followed for making market entry, what competitors are doing, etc.)
18. Strategic Recommendations
19. About Us & Disclaimer
(The company names can be customized according to the client's requirements)
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.